OCTO-TELEMATICS
20.5.2020 10:03:03 CEST | Business Wire | Press release
OCTO, a market leader in providing smart solutions by transforming its IoT Big Data set into actionable intelligence for a sustainable connected life, is pleased to announce the launch of two products designed to support companies' return back to business as they transition to the “new normal” following the COVID-19 pandemic. These innovative solutions encourage safe self-distancing and the robust sanitization of vehicles. At the forefront of the design principals, OCTO developed products are easy to implement and manage, while being highly effective. Protecting the workforce and their livelihoods, as well as protecting customers and fostering higher levels of trust.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200520005174/en/
OCTO AroundMe is based on OCTO’s proven SmartTag technology that utilises the latest Bluetooth standards, OCTO’s IoT cloud platform and is compatible with both iOS and Android smartphones. OCTO AroundMe allows for easy management of social distancing in both public and private spaces, such as stores or office buildings. The pocket-sized SmartTag carried by visitors or employees continuously monitor an individual’s proximity, in this case and under government guidelines this has been automatically set to two metres. Should two people inadvertently have a distance less than two meters apart, an audible alert would remind them to keep a safe distance. The event would also be captured anonymously and stored on the cloud for reporting and analysis, to better understanding and mitigate future risk. To further mitigate any risks, using OCTO AroundMe within closed environments also allows for easy and effective crowd control and building capacity management as it stores all entry and exit information.
OCTO PurePlace uses nano technology originally developed by the National Aeronautics and Space Administration (NASA), that eliminates viruses, bacteria, fungi as well as odours and volatile organic compounds in the air and on surfaces via a purifier. It is a non-invasive solution, safe to people and all materials commonly found within vehicle interiors. As well as the purifier device, the complete OCTO PurePlace solution consists of an onboard telematics device (OCTO SmartDiag or OCTO SuperEasy) and an application compatible with iOS and Android smartphones.
OCTO PurePlace has been designed to protect drivers and passengers across corporate fleets, rental fleets, carsharing and taxi operators. It allows for the easy and effective sanitization of vehicles during a trip with intermittent self-activation and the end of each journey with a full sanitization cycle. To ensure absolute safety and confidence, before entering the vehicle, both the driver and passenger can be notified regarding the state of sanitization via a smartphone app. For the operator and the safe management of the fleet, if the sanitization is not complete, the vehicle may be temporarily suspended from public use.
ABOUT OCTO
Founded in 2002, OCTO is a leading provider of telematic services and advanced data analytics for the insurance sector, and increasingly one of the leading companies offering solutions for Fleet Telematics and Smart Mobility. With OCTO’s unique propositions already established in the field of Insurtech and Smart Mobility, OCTO continues to expand in new sectors and international markets. In the context of an increasingly connected world, OCTO’s advanced analytics and its set of IoT Big Data, generates actionable analytics giving life to a new era of Smart Telematics. Today it has over 6 million connected users and the largest database of vehicle telematics data in the world, with over 267 billion miles of driving data collected and 473,000 claims and insurance events analysed. It also manages over 400,000 vehicle rentals per month.
OCTO does not guarantee, represent or warrant that the use of a photocatalytic oxidation purifier used in the OCTO PurePlace will prevent a vehicle’s occupant(s) from contracting any type of bacteria or virus-based illness, including, but not limited to, the common cold, coronavirus or influenza.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200520005174/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
